Continuing GLP-1 therapy in appropriate patients may therefore be protective rather than harmful
(2019) 8:e011037
Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity (Dated June 4, 2021)
Significant time and cost saving are possible compared to days or weeks using the traditional in vitro (e.g., microsomes) and/or in vivo methods (e.g., rodents, human, etc.)
But across all the other drugs, and the other trials, there was weight reduction and consistently it looks like there was a weight loss of between 3.5kg - 6.5kg favouring Ozempic with the bigger weight loss seen in the higher dose
Today's article will dive into how to naturally boost glutathione production, offering dietary and supplemental solutions
